Page 24 - Orvosoktatás - Aki a szívizom incfartust túlélte

24

A jelenlegi európai és amerikai ( STEMI, NSTEMI, Pre- with congestive heart failure: a subgroup analysis in
venció) ajánlások szerint – akut stádiumban I. ajánlás the cardiac insufficiency bisoprolol study (CIBIS II) Eur
a BB kezelés, ha nincs szívelégtelenség, kardiogén Heart J. 2003;24:552–9.
shok, illetve egyéb kontraindikációja a kezelésnek. 13. Randomised trial of intravenous atenolol among 16
Tartós BB kezelés javasolt STEMI, NSTEMI-t köve- 027 cases of suspected acute myocardial infarction:
tően I. ajánlás alapján, abban az esetben, ha nincs ISIS-1. First International Study of Infarct Survival
kontraindikáció. Collaborative Group. Lancet 1986;2:57-66.
14. Freemantle N, Cleland J, Young P, Mason J, Har-
I./A ajánlás alapján STEMI és NSTEMI-t követően rison J. beta Blockade after myocardial infarction:
metoprolol succinat, carvedilol, vagy bisoprolol ja- systematic review and meta regression analysis. BMJ
vasolt stabilizált HF és csökkent szisztolés funkció 1999;318:1730-7.
esetében, 15. Bangalore S, Steg G, Deedwania P, et al. β-Blocker
use and clinical outcomes in stable outpatients
1. ESC Guidelines for the diagnosis and treatment of with and without coronary artery disease. JAMA
acute and chronic heart failure 2012 European Heart 2012;308:1340-9.
Journal (2012) 33, 1787–1847. 16. Bangalore S, Makani H, Radford M, et al. Clinical
2. Bolger AP, Al-Nasser F. Beta-blockersforchronic outcomes with β-blockers for myocardial infarction:
HF: survivinglongerbut feeling better? Int Cardiol. a meta-analysis of randomized trials. Am J Med
2003;92:1–8. 2014;127:939-53.
3. CIBIS-II Investigators and Committees. The Card 17. Amsterdam EA, Wenger NK, Brindis RG, et al. 2014
iacInsufficiencyBisoprololStudy: a randomisedtrial. AHA/ACC Guideline for the Management of Patients
Lancet. 1999;353:9–13. with Non-ST-Elevation Acute Coronary Syndromes:
4. Campbell DJ, AggarwalA, Esler M, et al. Beta- a report of the American College of Cardiology/
blockers, angiotensin II, and ACE inhibitorsinpatients American Heart Association Task Force on Practice
withheartfailure. Lancet. 2001;358:1609–10 Guidelines. J Am Coll Cardiol 2014;64:e139-228.
5. CIBIS Investigators and Committees 1994. 18. O’Gara PT, Kushner FG, Ascheim DD, et al. 2013
A RandomizedTrial of beta-blockadeinheartfailure. ACCF/AHA guideline for the management of ST-
The CardiacInsufficiencyBisoprololStudy (CIBIS) elevation myocardial infarction: a report of the Ame-
Circulation. 90:1765–73. rican College of Cardiology Foundation/American
6. Cleland JG, KhandA, Clark A. The Heart Association Task Force on Practice Guidelines.
heartfailureepidemic: exactlyhowbig is it? EurHeart Circulation 2013;127:e362-425.
J. 2001;22:623–6. 19. Roffi M, Patrono C, Collet JP, et al. 2015 ESC
7. Dubach P, Myers J, Bonetti P, et al. Effects of Guidelines for the management of acute coronary
bisoprolol fumarate on left ventricula rsize, function, syndromes in patients presenting without persistent
and exercise capacity in patents with heart failure: ST-segment elevation: Task Force for the Manage-
analysis with magnetic resonance myocardial tagging. ment of Acute Coronary Syndromes in Patients
Am Heart J. 2002;143:676–83. [PubMed] Presenting without Persistent ST-Segment Elevation
8. Erdmann E, Lechat P, Verkenne P, et al. Resultsfrom of the European Society of Cardiology (ESC). Eur
post-hoc analyses of the CIBIS II trial: effect of Heart J 2016;37:267-315.
bisoprolol in high-risk patients groups with chronic
heart failure. Eur J Heart Fail. 2001;3:469–79.
9. Lechat P, Escolano S, Golmard JL, et al. Prognostic
value of bisoprolol-induced hemodynamic effects
in heart failure during the Cardiac Insufficiency
BIsoprolol Study (CIBIS) Circulation. 1997;96:2197–
205.
10. Lechat P, Hulot JS, Escolano S, et al. Heart rate and
cardiac rhythm relationships with bisoprolol benefit
in chronic heart failure in CIBIS II trial. Circulation.
2001;103:1428–1433.
11. LeizoroviczA, Lechat P, Cucherat M. Bisoprolol for
treatment of chronic heart failure: A meta-analysis on
individual data of two placebo-controlled studies-
CIBIS and CIBIS II. Am Heart J. 2002;143:301.
12. Simon T, Mary-Krause M, Funch-Brentano C.
Bisoprolol dose-response relationship in patients